Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP)
Immunological Aspects of Thrombotic Thrombocytopenic Purpura (TTP): Characterisation of B and T Lymphocytes Specific for the ADAMTS13 Autoantigen and Therapeutic Implications
University Hospital, Rouen
44 participants
May 11, 2023
OBSERVATIONAL
Conditions
Summary
The general objective of the proposed project is to characterise phenotypically and functionally ADAMTS13-specific memory B lymphocytes and autoreactive T lymphocytes, in particular follicular helper T lymphocytes, in the acute phase of the disease, but also during its progression after treatment. The aim is to highlight their contribution to the initial pathogenic process, their evolution under treatment, and also their involvement in patients who are refractory to immunosuppressive therapies and during relapses. The aim of this project is to identify early phenotypic or functional parameters that are predictive of relapse and that can be used for personalised optimisation of treatment to maintain remission.
Eligibility
Inclusion Criteria5
- age over 18
- patients with TTP at any stage of diagnosis (acute phase, lasting remission or not, relapse)
- patients undergoing internal medicine at Rouen University Hospital
- people who have read and understood the information letter
- membership of a social security scheme
Exclusion Criteria1
- \- a person deprived of liberty by an administrative or judicial decision or a person placed under court protection/guardianship or guardianship
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06945861